Abstract
Introduction: The thulium laser resection of bladder tumors (TmLRBT) was increasingly used in the treatment of non-muscle-invasive bladder cancer (NMIBC) recently, and here we report the relevant outcomes of our institution to evaluate its efficacy and safety. Methods: We retrospectively collected the data of NMIBC patients who underwent either TmLRBT or transurethral resection of bladder tumor (TURBT). The baseline characteristics and perioperative outcomes were compared in these 2 groups. Results: The TmLRBT had a higher rate of detrusor identification than TURBT (97.4 vs. 87.6%, p = 0.001). After screening, 134 patients who underwent TmLRBT and 152 patients who received TURBT were enrolled in the analysis, and their baseline characteristics were similar. During the TURBT, 24 (15.8%) obturator nerve reflexes and 9 (5.9%) bladder perforations occurred, while none happened during the TmLRBT. After surgery, TmLRBT patients had fewer postoperative gross hematuria (38.1 vs. 96.7%, p < 0.001) and postoperative irrigation (27.6 vs. 92.7%, p < 0.001), and its irrigation duration was significantly shorter (2.3 vs. 3.3 day, p < 0.001). During the follow-up, no significant difference in the recurrence rate was detected (p = 0.315). Conclusions: TmLRBT is a safer technique than conventional TURBT in the treatment of NMIBC, and it could offer better specimens for pathologic assessment while the cancer control was not compromised.
References
1.
Bray
F
, Ferlay
J
, Soerjomataram
I
, Siegel
RL
, Torre
LA
, Jemal
A
. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
. CA Cancer J Clin
. 2018
;68
(6
):394
–424
. .2.
Burger
M
, Catto
JW
, Dalbagni
G
, Grossman
HB
, Herr
H
, Karakiewicz
P
, Epidemiology and risk factors of urothelial bladder cancer
. Eur Urol
. 2013
;63
(2
):234
–41
. .3.
Babjuk
M
, Burger
M
, Compérat
EM
, Gontero
P
, Mostafid
AH
, Palou
J
, European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ): 2019 update
. Eur Urol
. 2019 Nov
;76
(5
):639
–57
.4.
Xu
J
, Wang
C
, Ouyang
J
, Sun
J
, Hu
C
. Efficacy and safety of transurethral laser surgery versus transurethral resection for non-muscle-invasive bladder cancer: a meta-analysis and systematic review
. Urol Int
. 2020
;104
(9–10
):810
–23
. .5.
Johnson
DE
, Cromeens
DM
, Price
RE
. Use of the holmium:YAG laser in urology
. Lasers Surg Med
. 1992
;12
(4
):353
–63
. .6.
Johnson
DE
. Use of the holmium:YAG (Ho:YAG) laser for treatment of superficial bladder carcinoma
. Lasers Surg Med
. 1994
;14
(3
):213
–8
. .7.
Li
C
, Gao
L
, Zhang
J
, Yang
X
, Liu
C
. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis
. Lasers Med Sci
. 2020 Jan 31
;35
:1025
–34
.8.
Xia
SJ
, Zhang
YN
, Lu
J
, Sun
XW
, Zhang
J
, Zhu
YY
, [Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia]
. Zhonghua Yi Xue Za Zhi
. 2005 Nov 30
;85
(45
):3225
–8
.9.
Gao
X
, Ren
S
, Xu
C
, Sun
Y
. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience
. BJU Int
. 2008 Nov
;102
(9
):1115
–8
. .10.
Wendt-Nordahl
G
, Huckele
S
, Honeck
P
, Alken
P
, Knoll
T
, Michel
MS
, Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate
. J Endourol
. 2008 May
;22
(5
):1041
–5
. .11.
Bach
T
, Wendt-Nordahl
G
, Michel
MS
, Herrmann
TR
, Gross
AJ
. Feasibility and efficacy of thulium:YAG laser enucleation (VapoEnucleation) of the prostate
. World J Urol
. 2009 Aug
;27
(4
):541
–5
. .12.
Yucel
M
, Hatipoglu
NK
, Atakanli
C
, Yalcinkaya
S
, Dedekarginoglu
G
, Saracoglu
U
, Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?
Urol Int
. 2010
;85
(3
):276
–80
. .13.
Tao
W
, Yang
D
, Shan
Y
, Xue
B
, Sun
C
, Zang
Y
, Safety and efficacy of 120W high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer
. J Xray Sci Technol
. 2013
;21
(2
):309
–16
. .14.
Xu
Y
, Guan
W
, Chen
W
, Xie
C
, Ouyang
Y
, Wu
Y
, Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: a prospective, randomized study
. Lasers Surg Med
. 2015 Apr
;47
(4
):306
–11
. .15.
Zhong
C
, Guo
S
, Tang
Y
, Xia
S
. Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience
. World J Urol
. 2010 Apr
;28
(2
):157
–61
. .16.
Liu
H
, Wu
J
, Xue
S
, Zhang
Q
, Ruan
Y
, Sun
X
, Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer
. J Int Med Res
. 2013 Aug
;41
(4
):984
–92
. .17.
Chen
X
, Liao
J
, Chen
L
, Qiu
S
, Mo
C
, Mao
X
, En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial
. World J Urol
. 2015 Jul
;33
(7
):989
–95
.18.
Migliari
R
, Buffardi
A
, Ghabin
H
. Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer
. J Endourol
. 2015 Nov
;29
(11
):1258
–62
. .19.
Zhang
XR
, Feng
C
, Zhu
WD
, Si
JM
, Gu
BJ
, Guo
H
, Two micrometer continuous-wave thulium laser treating primary non-muscle-invasive bladder cancer: is it feasible? A randomized prospective study
. Photomed Laser Surg
. 2015 Oct
;33
(10
):517
–23
. .20.
Huang
JH
, Hu
YY
, Liu
M
, Wang
GC
, Peng
B
, Yao
XD
. Comparative study of 2 um laser versus holmium laser for the resection of non-muscle invasive bladder cancer
. Int J Clin Exp Med
. 2016
;9
(12
):23618
–23
.21.
Xu
H
, Ma
J
, Chen
Z
, Yang
J
, Yuan
H
, Wang
T
, Safety and efficacy of en bloc transurethral resection with 1.9 microm vela laser for treatment of non-muscle-invasive bladder cancer
. Urology
. 2018 Mar
;113
:246
–50
.22.
Liang
JH
, Pan
YL
, Kang
J
, Qi
J
. Influence of irrigation on incision and coagulation of 2.0-μm continuous-wave laser: an ex vivo study
. Surg Laparosc Endosc Percutan Tech
. 2012 Jun
;22
(3
):e122
–5
.23.
Soloway
MS
, Masters
S
. Urothelial susceptibility to tumor cell implantation: influence of cauterization
. Cancer
. 1980 Sep 1
;46
(5
):1158
–63
. .24.
Soloway
MS
, Nissenkorn
I
, McCallum
L
. Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosourea
. Urology
. 1983 Feb
;21
(2
):159
–61
. .25.
Pode
D
, Alon
Y
, Horowitz
AT
, Vlodavsky
I
, Biran
S
. The mechanism of human bladder tumor implantation in an in vitro model
. J Urol
. 1986 Aug
;136
(2
):482
–6
. .26.
Hafner
C
, Knuechel
R
, Zanardo
L
, Dietmaier
W
, Blaszyk
H
, Cheville
J
, Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract
. Oncogene
. 2001
;20
(35
):4910
–5
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
